424 related articles for article (PubMed ID: 36945005)
1. Mesoporous nanodrug delivery system: a powerful tool for a new paradigm of remodeling of the tumor microenvironment.
Hang Y; Liu Y; Teng Z; Cao X; Zhu H
J Nanobiotechnology; 2023 Mar; 21(1):101. PubMed ID: 36945005
[TBL] [Abstract][Full Text] [Related]
2. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
3. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
Sa P; Sahoo SK; Dilnawaz F
Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
[TBL] [Abstract][Full Text] [Related]
6. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
[TBL] [Abstract][Full Text] [Related]
7. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment-activated self-recognizing nanodrug through directly tailored assembly of small-molecules for targeted synergistic chemotherapy.
Li Y; Lin J; Cai Z; Wang P; Luo Q; Yao C; Zhang Y; Hou Z; Liu J; Liu X
J Control Release; 2020 May; 321():222-235. PubMed ID: 32061620
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
Muntimadugu E; Kommineni N; Khan W
Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
Li M; Zhang F; Su Y; Zhou J; Wang W
Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
[TBL] [Abstract][Full Text] [Related]
11. Remodeling tumor microenvironment with nanomedicines.
Martin JD; Miyazaki T; Cabral H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
[TBL] [Abstract][Full Text] [Related]
12. Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery.
Wang X; Zhang H; Chen X; Wu C; Ding K; Sun G; Luo Y; Xiang D
Acta Biomater; 2023 Aug; 166():42-68. PubMed ID: 37257574
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.
Lin G; Chen S; Mi P
J Biomed Nanotechnol; 2018 Jul; 14(7):1189-1207. PubMed ID: 29944095
[TBL] [Abstract][Full Text] [Related]
14. The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles.
Meng X; Ma F; Yu D
Environ Res; 2024 Jan; 240(Pt 1):117362. PubMed ID: 37827371
[TBL] [Abstract][Full Text] [Related]
15. Complex interplay between tumor microenvironment and cancer therapy.
Shen M; Kang Y
Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
[TBL] [Abstract][Full Text] [Related]
16. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
17. Responsive and activable nanomedicines for remodeling the tumor microenvironment.
Zhang Y; Han X; Nie G
Nat Protoc; 2021 Jan; 16(1):405-430. PubMed ID: 33311713
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
[TBL] [Abstract][Full Text] [Related]
19. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.
Hu M; Huang L
Adv Drug Deliv Rev; 2022 Apr; 183():114137. PubMed ID: 35143893
[TBL] [Abstract][Full Text] [Related]
20. Accurate programmed multifunctional nano-missiles for self-promoted deep delivery and synergistic cascade tumor therapy: Tactfully collaborating chemosynthesis with tumor microenvironment remodeling.
Lu R; Wang S; Yang Z; Zhou L; Yang C; Wu Y
Theranostics; 2022; 12(12):5299-5316. PubMed ID: 35910803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
